This Week in Rheumatology: NIAMS research, FDA hearing

(MedPage Today) -- The research agenda for the National Institute of Arthritis and Musculoskeletal and Skin Diseases is likely to be the big story in rheumatology this week, but an FDA hearing and a new lupus journal will also drive headlines.
Source: MedPage Today Rheumatology - Category: Rheumatology Source Type: news
More News: Arthritis | Lupus | Rheumatology | Skin